Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamlodipine + bisoprolol fixed-dose combination in mild to moderate primary hypertension
CTR20192375Phase 2Completed
- Sponsor
- Shihuida Pharmaceutical Group
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Levamlodipine, bisoprolol in essential hypertension, sponsored by Shihuida Pharmaceutical Group. Started Dec 2019; status: completed.
02
Drugs
Levamlodipinebisoprolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20192375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192375.